99.3%
HPLC Verified
COA
Available
ISO
Certified Lab
Tirzepatide
Dual-action GIP/GLP-1 for maximum results
5mg vial | 5mg/vial
About Tirzepatide
Tirzepatide represents the next evolution in metabolic peptide therapy. As the first dual GIP/GLP-1 receptor agonist, it activates two incretin pathways simultaneously, producing weight loss results that have exceeded every previous compound studied.
The SURMOUNT-1 trial demonstrated that participants on the highest dose achieved an average weight loss of 22.5% of body weight over 72 weeks. This dual-agonist approach not only reduces appetite more effectively but also improves the body's ability to metabolize fat and regulate blood sugar.
GIP (glucose-dependent insulinotropic polypeptide) receptor activation enhances fat metabolism and energy expenditure, while GLP-1 receptor activation reduces appetite and slows digestion. Together, they create a synergistic effect that neither mechanism achieves alone.
Every batch of FormBlends Tirzepatide undergoes mass spectrometry analysis and endotoxin testing to ensure pharmaceutical-grade quality.
Key Benefits
Published Research
SURMOUNT-1 (N=2,539) demonstrated 22.5% mean weight loss at highest dose (15mg) over 72 weeks. 63% of participants achieved 20%+ weight loss vs 1.3% placebo. Also showed 2.24% A1C reduction in diabetic populations.
View Full Research LibraryCustomer Reviews for Tirzepatide
“I was 285 pounds with pre-diabetes and high blood pressure at 38. My wife was worried. I was worried. When I started researching GLP-1 options, Tirzepatide stood out because of the dual-action mechanism. Five months with FormBlends Tirzepatide and I have lost 63 pounds. But the numbers on the scale are not even the best part. My A1C went from 6.3 to 5.1. My blood pressure normalized. My doctor literally said 'whatever you are doing, keep doing it.' I have my energy back, I am playing basketball again, and my kids say I look ten years younger. Worth every penny.”
Marcus Johnson, 38
Denver, CO | 5 months
“I hit 260 pounds on my 50th birthday and had a wake-up call. My father died of a heart attack at 58. I did not want to follow the same path. I started Tirzepatide six months ago and the results have been life-changing. 72 pounds down, and every health marker has improved dramatically. My resting heart rate dropped from 82 to 62. My cholesterol is normal for the first time in a decade. I can run a 5K again. My wife says it is like being married to the guy she met in college. The science behind this compound is extraordinary, and FormBlends quality has been flawless batch after batch.”
David Chen, 51
San Francisco, CA | 6 months
Related Products
Semaglutide
The gold standard in GLP-1 weight management
Liraglutide
The proven GLP-1 pioneer with years of clinical data
AOD-9604
Fat-targeting fragment without growth hormone side effects